The Efficacy of Implementing Nurse-performed Ultrasound-guided Peripheral Intravenous Access in Oncology Patients

NCT ID: NCT06578494

Last Updated: 2024-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-16

Study Completion Date

2026-02-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the clinical efficacy of nurse-performed ultrasound-guided intravenous access in oncology patients on the oncological outpatient unit in the National Hospital of the Faroe Islands.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project is prospective, interventional, clinical study aligned in four different time stages.

In the first stage, the pre-implementation stage, procedures are as usual, where the patient receives intravenous access via the use of the traditional palpation technique and data will be registered. In the next stage, the training stage, the nurses on the oncological outpatient unit will be trained in the use of the ultrasound-guided technique to place peripheral intravenous catheters and will be supervised by specialists in ultrasound. In the third stage, the implementation stage, the nurses will use the ultrasound technique as a daily routine in their practice. In the fourth stage, the post-implementation stage, the same data registration as in the first stage will be registered (see outcome measures) and the results will be compared in order to see the efficacy before and after implementation of ultrasound guidance. It is estimated a total sample of 100 cannulation procedures with approximately 30 patients needed in the pre-implementation and post-implementation stages.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Supportive Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

FACTORIAL

This is a before and after study, where the patients pre-implementation stage receive intravenous access via the traditional palpation technique and in the post-implementation stage receive ultrsound-guided intravenous cannulation.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultrasound-guided peripheral intravenous access

The patients in the experimental arm will receive ultrasound-guided peripheral intravenous catheter placement, where the dynamic needle tip (DNTP) approach (short-axis) will be used.

Group Type EXPERIMENTAL

Ultrasound

Intervention Type DEVICE

Ultrasound-guided peripheral intravenous catheter insertion

Traditional palpation intravenous access technique

The comparator group will receive the traditional palpation intravenous access technique.

Group Type ACTIVE_COMPARATOR

Ultrasound

Intervention Type DEVICE

Ultrasound-guided peripheral intravenous catheter insertion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Ultrasound-guided peripheral intravenous catheter insertion

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cancer patients admitted to the oncological outpatient unit are eligible for inclusion if they are scheduled for treatment with chemotherapy requiring placement of peripheral intravenous catheter, aged 18 years or older, and reside in the Faroe Islands.

Exclusion Criteria

* Lack of informed consent and mental incapacity.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Hospital of the Faroe Islands

OTHER_GOV

Sponsor Role collaborator

University of the Faroe Islands

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role collaborator

Faroese Hospital System

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Juhl-Olsen, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Aarhus University Hospital

August Gabriel Wang, MD, DMSc

Role: PRINCIPAL_INVESTIGATOR

University of the Faroe Islands

Lisa Maria Anderssen, RN, MHS

Role: PRINCIPAL_INVESTIGATOR

Department of Research, the National Hospital of the Faroe Islands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lisa Maria Anderssen, RN, MHS

Role: CONTACT

(+298) 223820

Maria Skaalum Petersen, MSc, PhD

Role: CONTACT

(+298) 216695

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ultrasound IV

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.